Nuveen’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.01M Buy
302,196
+1,732
+0.6% +$15.5K ﹤0.01% 2107
2025
Q4
$2.54M Buy
300,464
+12,014
+4% +$85.7K ﹤0.01% 2188
2025
Q3
$1.51M Hold
288,450
﹤0.01% 2421
2025
Q2
$998K Sell
288,450
-31,945
-10% -$95K ﹤0.01% 2605
2025
Q1
$839K Sell
320,395
-333,033
-51% -$1.3M ﹤0.01% 2712
2024
Q4
$2.69M Buy
653,428
+378,322
+138% +$2.06M ﹤0.01% 2259
2024
Q3
$1.95M Sell
275,106
-171,702
-38% -$1.28M ﹤0.01% 2424
2024
Q2
$2.91M Buy
446,808
+184,925
+71% +$1.26M ﹤0.01% 2199
2024
Q1
$2.17M Hold
261,883
﹤0.01% 2367
2023
Q4
$2.88M Buy
261,883
+3,413
+1% +$28.8K ﹤0.01% 2239
2023
Q3
$2.17M Sell
258,470
-1,612
-0.6% -$17.3K ﹤0.01% 2264
2023
Q2
$3.27M Buy
260,082
+9,145
+4% +$114K ﹤0.01% 2121
2023
Q1
$4.13M Buy
250,937
+15,734
+7% +$282K ﹤0.01% 1996
2022
Q4
$3.51M Sell
235,203
-38,975
-14% -$746K ﹤0.01% 2114
2022
Q3
$6.13M Buy
274,178
+4,332
+2% +$95.1K ﹤0.01% 1779
2022
Q2
$4.52M Buy
269,846
+52,523
+24% +$1.13M ﹤0.01% 2011
2022
Q1
$5.63M Buy
217,323
+5,272
+2% +$128K ﹤0.01% 1995
2021
Q4
$5.93M Sell
212,051
-2,167
-1% -$68.5K ﹤0.01% 2025
2021
Q3
$7.95M Buy
214,218
+6,707
+3% +$226K ﹤0.01% 1944
2021
Q2
$7.59M Buy
207,511
+50,977
+33% +$1.68M ﹤0.01% 2020
2021
Q1
$5.41M Buy
156,534
+27,843
+22% +$1.21M ﹤0.01% 2135
2020
Q4
$5.35M Buy
128,691
+2,652
+2% +$120K ﹤0.01% 2039
2020
Q3
$5.37M Buy
+126,039
New +$4.81M ﹤0.01% 1879

Other funds holding RLAY